06:28

Endometrial Cancer Care | Key Barriers and Solutions

04:08

Endometrial Cancer Disparities | Elevating Awareness of Diagnosis and Access Gaps

04:17

A Patient’s Proactive Path to an Acute Myeloid Leukemia Diagnosis

04:30

Advice for Setting Myeloma Treatment Goals and Collaborating on Care Decisions

32:14

HCP Roundtable: Breaking Barriers and Cultivating Clinical Excellence in Endometrial Cancer Care

04:54

Stomach Cancer Screening | How Asian and Latinx Patients Can Self-Advocate

03:00

Potential Impact of Artificial Intelligence on Stomach Cancer Detection and Care

06:19

What Stomach Cancer Care Obstacles Do Asian and Latinx Patients Face?

04:12

Can Stomach Cancer Risk Be Reduced by Treatment and Lifestyle Changes?

03:50

What Are Key Risk Factors for Stomach Cancer?

03:13

How Biomarkers Might Impact Future Stomach Cancer Care

04:09

How Can Public Policy Measures Reduce Gastric Cancer in High-Risk Populations?

03:14

What Is the Role of Biomarker Testing in Stomach Cancer?

04:40

What Are the GAPS Study Key Findings About Gastric Precancer?

03:04

What Key Ways Is Early Detection of Stomach Cancer Delayed?

02:52

Dr. Joo Ha Hwang: Why Is It Important for You to Empower Patients?

02:16

Explaining Advanced Non-Small Cell Lung Cancer to Veterans and Their Families

04:21

Equitable Access: Overcoming Challenges in Precision Medicine for Veterans with Lung Cancer

03:10

Do Veterans Face Health Disparities in Lung Cancer Care?

04:31

Do Disparities Exist for Black and Latinx Veterans Facing Lung Cancer?

03:14

What Should Veterans Know About Lung Cancer Screening and Risk?

01:49

What Impact Does the VA Have on Lung Cancer Care Coordination?

03:12

Navigating Lung Cancer Clinical Trials: VA Support and Resources for Veterans

04:58

Can Veterans in Rural Areas Facing Lung Cancer Access Experts Via Telemedicine?

04:03

Breaking Barriers: Enhancing Veteran Support in Lung Cancer Care

03:37

Are There Lung Cancer Clinical Trials Studying Veterans?

01:39

Dr. Michael Kelley: Why Is It Important for You to Empower Patients?

02:28

Empowered by Biomarker Testing: Amber’s Journey with Stage IV NSCLC

07:48

Choosing Therapy | How Are AML Treatment Goals Determined?

04:26

What Are AML Inhibitor Therapies and How Do They Work?

02:28

What AML Patients Should Understand About Test Results

08:21

Expert Overview | AML Treatment Options and Phases of Therapy

02:35

What Key Testing Occurs Following an AML Diagnosis?

02:46

Empowered Care: A Patient's Guide to Navigating Endometrial Cancer

03:22

What Does Cancer Survivorship Mean?

05:44

Cancer Survivorship | Ongoing Healthcare and Follow-Up

06:28

Cancer Survivorship | The Positive Impact of Peer Support

21:25

Cancer Survivorship | An Expert and a Survivor Share Inspiration and Advice

01:40

Non-Melanoma Skin Cancer Staging | What Patients Should Know

05:46

dvanced Non-Melanoma Skin Cancer Test Results | Understanding YOUR Disease

02:31

What Patients Should Know About Non-Melanoma Skin Cancer Progression

06:44

Advanced Non-Melanoma Skin Cancer | Establishing a Treatment Plan

01:58

Advances in Non-Melanoma Skin Cancer Treatment and Monitoring

03:48

Advice for Accessing Advanced Non-Melanoma Skin Cancer Clinical Trials

02:41

What Are Non-Melanoma Skin Cancers and Where Do They Develop?

32:32

Elevate | What You Should Know About Your Role in AML Treatment and Care Decisions

03:12

Miguel’s Journey: Embracing CAR T-cell Therapy as a Latinx Myeloma Survivor

28:51

Advanced Non-Melanoma Skin Cancer Treatment | Partnering With Your Team on Care Decisions

08:17

What Are Potential Impacts of Artificial Intelligence on AML Patient Care?

00:31

What Is the Role of Bone Marrow Biopsies in AML Treatment?

04:07

Why Is Shared Decision-Making Important for AML Patients?

03:39

Do AML Bone Marrow Biopsies Show Racial and Ethnic Variances?

02:46

How Bone Marrow Biopsies Impact Acute Myeloid Leukemia Treatment and Care

04:03

Novel AML Therapy Use | Impact of Socioeconomic Status and Other Factors

03:42

Underrepresented AML Clinical Trial Groups | What Solutions Are Underway?

04:57

Why Is Post-Access Enrollment Vital in AML Clinical Trial Participation?

06:52

What Are Key Acute Myeloid Leukemia Care Barriers and Solutions?

04:16

What AML Clinical Trial Inequities Do Minority and Ethnic Groups Face?

01:44

Dr. Andrew Hantel: Why Is It Important for You to Empower Patients?

05:59

What Are Myeloma Risk Factors for Veterans and First Responders?